SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001267602-19-000099
Filing Date
2019-07-22
Accepted
2019-07-22 19:38:08
Documents
1
Period of Report
2019-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_156383866775006.html 3  
1 FORM 3 wf-form3_156383866775006.xml 3 1735
  Complete submission text file 0001267602-19-000099.txt   3115
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Issuer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ALIMERA SCIENCES, INC. 6120 WINDWARD PARKWAY, SUITE 290 ALPHARETTA GA 30005
Business Address
Snisarenko John (Reporting) CIK: 0001783264 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34703 | Film No.: 19966632